Smallpox vaccination site complications

International Journal of Dermatology

Volumn 45, Issue 6, 2006, Pages 684-688

  Waibel, Kirk H ^a   Walsh, Douglas S ^a  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; SMALLPOX VACCINE; STEROID; VACCINIA VACCINE;

BASAL CELL CARCINOMA; BENIGN TUMOR; CANCER SURGERY; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DISCOID LUPUS ERYTHEMATOSUS; FIBROHISTIOCYTOMA; FIBROSARCOMA; GRAVES DISEASE; HEALTH CARE PERSONNEL; HERPES SIMPLEX; HUMAN; HYPERTROPHIC SCAR; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; KELOID; MALIGNANT FIBROUS HISTIOCYTOMA; MELANOMA; PATIENT COUNSELING; PHYSICAL EXAMINATION; PIGMENT DISORDER; REVIEW; SCAR; SEBACEOUS NEVUS; SMALLPOX; SQUAMOUS CELL CARCINOMA;

CICATRIX; HUMANS; NEVUS; SKIN DISEASES; SKIN NEOPLASMS; SMALLPOX VACCINE;

EID: 33745957419     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02627.x     Document Type: Review

References (59)

1. Centers for Disease Control and Prevention. Smallpox Vaccination Program Status by State: http://www.cdc.gov/od/oc/media/spvaccin.htm
2. Department of Defense. Department of Defense Smallpox Vaccination Program: http://www.smallpox.army.mil/media/pdf/Spsafetysum6.pdf
3. Waibel KH, Ager EP, Topolski RL, et al. A randomized trial comparing vaccinia on the external surfaces of 3 conventional bandages applied to smallpox vaccination sites in primary vaccinees. Clin Infect Dis 2004; 39: 1004-1007.
4. Wharton M, Strikas RA, Harpaz R, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52: 1-16.
5. Thorne CD, Hirshon JM, Himes CD, et al. Emergency medicine tools to manage smallpox (vaccinia) vaccination complications: Clinical practice guideline and policies and procedures. Ann Emerg Med 2003; 42: 665-680.
6. Regan TD, Norton SA. The scarring mechanism of smallpox. J Am Acad Dermatol 2004; 50: 591-594.
7. Waibel KH, Walsh DS. Smallpox vaccination site reactions: 2 cases of exaggerated scarring and a brief review. Int J Dermatol. DOI: 10.1111/ j.1365-4632.2004.02437.x
8. Musgrave RM. The pitfall of surgical excision of vaccination scars in the deltoid area. Plast Reconstr Surg 1973; 51: 198-199.
9. Waddington E, Bray PT, Evans AD, et al. Cutaneous complications of mass vaccination against smallpox in South Wales 1962. Trans St Johns Hosp Dermatol Soc 1964; 50: 22-42.
10. Nemeth AJ. Keloids and hypertrophic scars. J Dermatol Surg Oncol 1993; 19: 738-746.
11. Curth H, Curth W, Garb J. Cutaneous complications of mass vaccination in New York City, 1947. J Invest Dermatol 1948; 10: 167-188.
12. Gordon H. Complications of smallpox vaccination: Basal cell carcinoma, keloids, and acute bullous reactions. Cutis 1974; 13: 444-447.
13. Lee TY, Chin GS, Kim WJ, et al. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999; 43: 179-184.
14. Chodon T, Sugihara T, Igawa HH, et al. Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol 2000; 157: 1661-1669.
15. Tredget EE, Nedelec B, Scott PG, et al. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 1997; 77: 701-730.
16. Pariser RJ. Benign neoplasms of the skin. Med Clin North Am 1998; 82: 1285-1307, v-vi.
17. Rubin Z, Hyman AB. Nodulus cutaneus with hemorrhage in a smallpox vaccination scar. Arch Dermatol 1965; 92: 406-409.
18. Hendricks WM. Dermatofibroma occurring in a smallpox vaccination scar. J Am Acad Dermatol 1987; 16: 146-147.
19. Porter D, Earle J. Jadassohn tumour arising at smallpox vaccination site. Br J Dermatol 1972; 86: 177-179.
20. Lupton JR, Elgart ML, Sulica VI. Segmental neurofibromatosis in association with nevus sebaceus of Jadassohn. J Am Acad Dermatol 2000; 43: 895-897.
21. Goncalves JC. Malignant change in smallpox vaccination scars. Arch Dermatol 1966; 93: 229-230.
22. Friedman MM, Miller-Cranko JA. Malignancy in a smallpox vaccination scar. Report on another case. Cent Afr J Med 1972; 18: 142.
23. Castrow FF, Williams TE. Basal-cell epithelioma occurring in a smallpox vaccination scar. J Dermatol Surg 1976; 2: 151-152.
24. Kulwin MH. Basal cell epithelioma in smallpox vaccination scar fifty years later. IMJ Ill Med J 1975; 148: 612-613.
25. Marmelzat WL. Malignant tumors in smallpox vaccination scars: A report of 24 cases. Arch Dermatol 1968; 97: 400-406.
26. Rich JD, Shesol BF, Horne DW, 3rd. Basal cell carcinoma arising in a smallpox vaccination site. J Clin Pathol 1980; 33: 134-135.
27. Reed WB, Wilson-Jones E. Malignant tumors as a late complication of vaccination. Arch Dermatol 1968; 98: 132-135.
28. Riley KA. Basal cell epithelioma in smallpox vaccination scar. Report of a case. Arch Dermatol 1970; 101: 416-417.
29. Dorsey CS, Marmelzat W, Levan N. Skin cancer in smallpox vaccination scars: A report of five cases. Cardiologia 1960; 92: 353.
30. Washington L, Jacobs P. Basal cell carcinoma in a vaccination scar. Cutis 1971; 8: 557.
31. Weary P. Basal cell carcinoma arising at site of smallpox vaccination. Cutis 1967; 3: 1114.
32. Zelickson AS. Basal cell epithelioma at site and following smallpox and vaccination. Arch Dermatol 1968; 98: 35-36.
33. Upton G, Wilson J. Basal cell carcinoma arising in a vaccination scar. Cutis 1973; 11: 49-51.
34. Skidmore RA Jr, Flowers FP. Nonmelanoma skin cancer. Med Clin North Am 1998; 82: 1309-1323, vi.
35. Marmelzat WL, Martel S. Malignant melanomas in smallpox vaccination scars. Report of six cases. Arch Dermatol 1964; 89: 823-826.
36. De Oreo G. Primary malignant melanoma in a smallpox vaccination scar: report of a case and review of the literature. Int J Dermatol 1973; 12: 217-219.
37. Lane JM, Ruben FL, Neff JM, et al. Complications of smallpox vaccination, 1968: Results of ten statewide surveys. J Infect Dis 1970; 122: 303-309.
38. Pfahlberg A, Kolmel KF, Grange JM, et al. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. J Invest Dermatol 2002; 119: 570-575.
39. Lang PG Jr. Malignant melanoma. Med Clin North Am 1998; 82: 1325-1358.
40. Rea E. Squamous carcinoma on vaccination scar. S Afr Med J 1956; 30: 499.
41. Green JJ, Heymann WR. Dermatofibrosarcoma protuberans occurring in a smallpox vaccination scar. J Am Acad Dermatol 2003; 48: S54-S55.
42. Kahn HJ, Fekete E, From L. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: Comparison with CD34 and factor XIIIa. Hum Pathol 2001; 32: 50-56.
43. Calikoglu E, Augsburger E, Chavaz P, et al. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. J Cutan Pathol 2003; 30: 185-189.
44. Li N, McNiff J, Hui P, et al. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: Potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. Am J Dermatopathol 2004; 26: 267-272.
45. Okita H, Ohtsuka T, Yamazaki S. Flow-cytometric DNA analysis in cutaneous fibrohistiocytic tumors. Dermatology 2003; 207: 357-361.
46. Slater DN, Parsons MA, Fussey IV. Malignant fibrous histiocytoma arising in a smallpox vaccination scar. Br J Dermatol 1981; 105: 215-217.
47. Stadler FJ, Scott GA, Brown MD. Malignant fibrous tumors. Semin Cutan Med Surg 1998; 17: 141-152.
48. Archampong EQ, Clark CG. Fibrosarcoma at the site and immediately following small-pox vaccination. Br J Surg 1970; 57: 937-938.
49. Helman J. Pigmented vaccination scars. S Afr Med J 1978; 53: 430.
50. Kumar LR, Goyal BG. Pigmented hairy scar following smallpox vaccination. Indian J Pediatr 1968; 35: 283-284.
51. Li-Tsang CW, Lau JC, Liu SK. Validation of an objective scar pigmentation measurement by using a spectrocolorimeter. Burns 2003; 29: 779-784.
52. Onwukwe MF. Cutaneous complications of smallpox vaccination scars. Int J Dermatol 1973; 12: 290-294.
53. Pujol RM, Monmany J, Bague S, et al. Graves' disease presenting as localized myxoedematous infiltration in a smallpox vaccination scar. Clin Exp Dermatol 2000; 25: 132-134.
54. Inappropriate use of smallpox vaccine. FDA Drug Bull 1982; 12: 12.
55. Mintz L. Recurrent herpes simplex infection at a smallpox vaccination site. J Am Med Assoc 1982; 247: 2704-2705.
56. Grime P. BCG re-vaccination. Thorax 2001; Vol 56: 741-742.
57. Copcu E, Aktas A, Sisman N, et al. Thirty-one cases of Marjolin's ulcer. Clin Exp Dermatol 2003; 28: 138-141.
58. Walsh DS. Molecular genetics of skin cancer. Adv Dermatol 1997; 13: 167-204.
59. Carruthers R. A preferable site for vaccination. Med J Aust 1969; 1: 1174-1177.